No Data
No Data
MEDICSKIN: Interim Report 2024
MEDICSKIN: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED 30 SEPTEMBER 2024
MEDICSKIN: ANNUAL REPORT 2023/24
Medicskin (08307) released its annual performance, with shareholders' attributable losses of HKD 3.048 million, a year-on-year narrowing of 13.8%.
Zhitong Finance APP news, medicskin (08307) released its annual performance for the year ended March 31, 2024, with revenue of HKD 49.135 million, a year-on-year increase of 7.9%; Shareholders' deficit narrowed by 13.8% to HKD 3.048 million; Basic loss per share was 0.77 HK cents. The main reason for the reduction in losses during the period was due to follow-up adjustments made to employee costs of HKD 700,000 recognized in the comprehensive income statement for the year ended March 31, 2023, while the employee cost related to long-term service commitment recognized for the year ended March 31, 2024 was HKD 100,000. This adjustment was made
MEDICSKIN: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED 31 MARCH 2024
Midis Skin (08307): Midea signs a lease agreement with Harbour City Real Estate to renew the leasing of Hong Kong properties
Midis Skin (08307) issued an announcement. On May 21, 2024, the tenant Miji Dermatology Co., Ltd...
No Data